Meeting
2019 ASCO Annual Meeting
Adjuvant chemotherapy to improve survival in average-risk adult medulloblastoma patients: Long-term results.
Authors
Giuseppe Lamberti
Department of Medical Oncology S.Orsola Malpighi Hospital Bologna, Bologna, Italy
Giuseppe Lamberti , Enrico Franceschi , Alicia Tosoni , Santino Minichillo , Monica Di Battista , Alexandro Paccapelo , Carmelo Sturiale , Maurizio Mascarin , Barbara Masotto , Lorenzo Volpin , Stefania Bartolini , Felice Giangaspero , Alba Ariela Brandes
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Central Nervous System Tumors
Track
Central Nervous System Tumors
Sub Track
Central Nervous System Tumors
Citation
J Clin Oncol 37, 2019 (suppl; abstr 2037)
DOI
10.1200/JCO.2019.37.15_suppl.2037
Abstract #
2037
Poster Bd #
226
Abstract Disclosures
Similar Posters
Poster
2020 ASCO Virtual Scientific Program
Delayed adjuvant radiotherapy in early-stage cervical cancer with intermediate-risk features has a detrimental effect on survival that cannot be corrected by adjuvant chemotherapy.
First Author: Joyson Kodiyan
Poster
2020 Genitourinary Cancers Symposium
Prospective trial of adjuvant chemotherapy versus adjuvant radiation therapy for locally advanced bladder cancer after radical cystectomy.
First Author: Mohamed S. Zaghloul
Poster
2019 Gastrointestinal Cancers Symposium
Adjuvant chemotherapy with or without sequential radiation in resected pancreatic adenocarcinoma: Who will win RTOG 0848?
First Author: Ashwin Shinde
Poster
2019 Gastrointestinal Cancers Symposium
Adjuvant therapy is associated with improved survival in pT1N1 gastric cancer in a heterogeneous western patient population.
First Author: Matthew R. Porembka